ADRB2 and myocardial infarction: Although it is known that β-blockers attenuate myocardial damage and long-term pathological remodeling caused by β-AR overactivation to improve cardiac function, it would provide a definitive explanation for the improvement of cardiac function by β-blockers in MI patients from the perspective of heart regeneration.